name	column	regex	Gene	Therapeutic	Gene Acession (NC_063383)	Protein	Start (nt)	Stop (nt)	Resistance Mutations	Residues of interest	References	Virus-Specific Validation
Tecovirimat   OPG057:H238Q	aaSubstitutions	.*OPG057:H238Q.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29788	29790	H238Q	238	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:Y258C	aaSubstitutions	.*OPG057:Y258C.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29848	29850	Y258C	258	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:N267D	aaSubstitutions	.*OPG057:N267D.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29875	29877	N267D	267	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:D283G	aaSubstitutions	.*OPG057:D283G.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29923	29925	D283G	283	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:A288P	aaSubstitutions	.*OPG057:A288P.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29938	29940	A288P	288	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:A290V	aaSubstitutions	.*OPG057:A290V.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29944	29946	A290V	290	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:D294V	aaSubstitutions	.*OPG057:D294V.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29956	29958	D294V	294	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:A295E	aaSubstitutions	.*OPG057:A295E.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29959	29961	A295E	295	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:I372N	aaSubstitutions	.*OPG057:I372N.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	30190	30192	I372N	372	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:T289A	aaSubstitutions	.*OPG057:T289A.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29941	29943	T289A	289	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:P243S	aaSubstitutions	.*OPG057:P243S.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29803	29805	P243S	243	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:T220A	aaSubstitutions	.*OPG057:T220A.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29734	29736	T220A	220	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:T220I	aaSubstitutions	.*OPG057:T220I.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29734	29736	T220I	220	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:T245I	aaSubstitutions	.*OPG057:T245I.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29809	29811	T245I	245	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:A265D	aaSubstitutions	.*OPG057:A265D.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29869	29871	A265D	265	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:N267del	aaDeletions	.*OPG057:N267-.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29875	29877	N267del	267	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Tecovirimat   OPG057:L297ins	aaInsertions	.*OPG057:297:.*	F13L	Tecovirimat	OPG057	Palmytilated EEV membrane protein 	29965	29967	L297ins	297	"Mertes, H., Rezende, A. M., Brosius, I., Naesens, R., Michiels, J., deBlock, T., ... & Vercauteren, K. (2023). Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Annals of Internal Medicine, 176(8), 1141-1143. Smith, T. G., Gigante, C. M., Wynn, N. T., Matheny, A., Davidson, W., Yang, Y., ... & Hutson, C. L. (2023). Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerging Infectious Diseases, 29(12), 2426. Garrigues, J. M., Hemarajata, P., Karan, A., Shah, N. K., Alarc, J., Marutani, A. N., ... & Green, N. M. (2023). Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County. Antimicrobial Agents and Chemotherapy, 67(7), e00568-23."	MPOX
Brincidofovir/Cidofovir   OPG071:A314T	aaSubstitutions	.*OPG071:A314T.*	E9L	Brincidofovir/Cidofovir	OPG071	DNA polymerase (2)	52357	52359	A314T	314	"Kannan, S. R., Sachdev, S., Reddy, A. S., Kandasamy, S. L., Byrareddy, S. N., Lorson, C. L., & Singh, K. (2022). Mutations in the monkeypox virus replication complex: potential contributing factors to the 2022 outbreak. Journal of Autoimmunity, 133, 102928."	MPOX
Brincidofovir/Cidofovir   OPG071:A684V	aaSubstitutions	.*OPG071:A684V.*	E9L	Brincidofovir/Cidofovir	OPG071	DNA polymerase (2)	53467	53469	A684V	684	"Kannan, S. R., Sachdev, S., Reddy, A. S., Kandasamy, S. L., Byrareddy, S. N., Lorson, C. L., & Singh, K. (2022). Mutations in the monkeypox virus replication complex: potential contributing factors to the 2022 outbreak. Journal of Autoimmunity, 133, 102928."	MPOX
